Acute liver failure secondary to hepatic infiltration: A single centre experience of 18 cases

Gut

Volumn 42, Issue 4, 1998, Pages 576-580

  Rowbotham, D ^a   Wendon, J ^a   Williams, R ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Acute liver failure; Diagnosis; Hepatic infiltration; Histology; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID; IMMUNOGLOBULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEMOPHAGOCYTIC SYNDROME; HODGKIN DISEASE; HUMAN; LIVER BIOPSY; LIVER FAILURE; LIVER METASTASIS; LIVER NECROSIS; MALE; MORTALITY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031950220     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.42.4.576     Document Type: Article

References (54)

1. Willis RA. The spread of tumours in the human body. London: Butterworths, 1973.
2. Cello JP, Grendell JH. The liver in systemic conditions. In: Zakim D, Boyer TD, eds. Hepatology. A textbook of liver discase. Philadelphia: WB Saunders, 1990:1423-5.
3. Fairbank WHD. Three atypical cases of Hodgkin's disease presenting with liver failure. Can .Med Assoc J 1953;69:315 17.
4. Trewby PN, Portmann B, Brinkley DM, et al. Liver disease as presenting manifestation of Hodgkin's disease. Q J Med 1979;48:137 50.
5. Lefkowitch JH, Falkow S, Whitlock RT. Hepatic Hodgkin's disease simulating cholestatic hepatitis with liver failure. Arch Pathol Lab Med 1985;109:424 6.
6. Braude S, Gimson AE, Portmann B, et al. Fulminant hepatic failure in non-Hodgkin's lymphoma. Postgrad Med J 1982;58:301 4.
7. Ghosh P, Fox IJ, Rader AM, et al. Fulminant hepatic failure as the initial manifestation of non-Hodgkin's lymphoma. Am J Gastroenterol 1995;90:2207 9.
8. Woolf GM, Petrovic LM, Rojter SE, et al. Acute liver failure due to lymphoma. A diagnostic concern when considering liver transplantation. Dig Dis Sci 1994;39:1351 8.
9. Gargot D, Maitre F, Causse X, et al. Primary liver non-Hodgkin's lymphoma presenting as fulminant hepatic disease. Gastroenterol Hepatol 1994;6:843 6.
10. Salo J, Nomdedeu B, Bruguera M, et al. Acute liver failure due to non-Hodgkin's lymphoma. Am J Gastroenterol 1993; 88:774 6.
11. Colby TV, LaBrecque DR. Lymphoreticular malignancy presenting as fulminant hepatic disease. Gastroenterology 1982;82:339-45.
12. Crotty CP, Winkelmann RK. Cytophagic histiocytic panniculitis with fever, cytopenia, liver failure and terminal haemorrhagic diathesis. J Am Acad Dermatol 1981;4:181 94.
13. Beaugrand M, Trinchet JC, Callard P, et al. Malignant histiocytosis presenting as a fulminant hepatic disease [letter]. Gastroenterology 1983;84:447 8.
14. Hess CE, Joyce RA. Acute myeloblastic leukaemia presenting as progressive hepatic failure. South Med J 1981;74: 1028 9.
15. Zafrani ES, Leclercq B, Vernant JP, et al. Massive blastic infiltration of the liver: a cause of fulminant hepatic failure. Hepatology 1983;3:428 32.
16. Greer JP, Cousar JB, Miller RF, et al. T4 (helper phenotype) chronic lymphocytic leukaemia: a case report with liver failure and literature review. Med Pediatr Oncol 1988;16:356 62.
17. Eras P, Sherlock P. Hepatic coma secondary to metastatic liver disease. Ann Intern Med 1971;74:581 3.
18. Harrison HB, Middleton HM, Crosby JH, et al. Fulminant hepatic failure: an unusual presentation of metastatic liver disease. Gastroenterology 1981;80:820 5.
19. Myszor MF, Record CO. Primary and secondary malignant disease of the liver and fulminant hepatic failure. J Clin Gastroenterol 1990;12:441 6.
20. Krauss EA, Ludwig PW, Sumner HW. Metastatic carcinoma presenting as fulminant hepatic failure. Am J Gastroenterol 1979;72:651 4.
21. Nouel O, Bernuau J, Lebrec D, et al. Severe hepatic failure and portal hypertension due to metastatic carcinoma of the liver. Gastroenterol Clin Biol 1979;3:135 7.
22. Bouloux PM, Scott RJ, Goligher JE, et al. Fulminant hepatic failure secondary to diffuse liver infiltration by melanoma. J R Soc Med 1986;79:302 3.
23. Stein AM, Fawaz K, Tabrizi A, et al. Multifocal malignant haemangioendothelioma presenting as acute hepatitis. A clinicopathologic study. Am J Gastroenterol 1977;67:370 4.
24. Biemer JJ. Hepatic manifestations of lymphomas. Ann Clin Lab Sci 1984;14:252 60.
25. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342:273 5.
26. Roth A, Kolaric K, Dominis M. Histologic and cytologic liver changes in 120 patients with malignant lymphomas. Tumori 1978;64:45 53.
27. Kim H, Dorfman RF. Morphological studies of 84 untreated patients subjected to laparotomy for the staging of non-Hodgkin's lymphoma. Cancer 1974;33:657 74.
28. Fergusson DJ, Allen LW, Griem ML, et al. Surgical experience with staging laparotomy in 125 patients with lymphoma. Arch Intern Med 1973;131:356 61.
29. Sasadeusz J, Buehanan M, Speed B. Reactive haemophagocytic syndrome in human immunodeficiency virus infection. J Infect 1990;20:65 8.
30. Huang LM, Lee CY, Lin KH, et al. Human herpesvirus-6 associated with fatal haemophagocytic syndrome [letter]. Lancet 1990;336:60 1.
31. Ohshima K, Kikuchi M, Eguchi F, et al. Virus-associated haemophagocytic syndrome with Epstein-Barr virus infection. Virchows Arch A 1991;419:519 22.
32. Ramanathan M, Duraisamy G. Haemophagocytosis in dengue haemorrhagic fever: a case report. Ann Acad Med Singapore 1991;20:803-4.
33. Watanabe M, Shimamoto Y, Yamaguchi M, et al. Viral-associated haemophagocytosis and elevated serum TNF-alpha with parvovirus-B19-related pancytopenia in patients with hereditary spherocytosis. Clin Lab Haematol 1994;16 179 82.
34. Kondo H, Date Y. Effects of simultaneous rhG-CSF and methylprednisolone "pulse" therapy on hepatitis A virus-associated haemophagocytic syndrome. Eur J Haematol 1995;54:271 3.
35. Bhatia VN, Parmar U, Subramanian C, et al. Virulence, haemolysis pattern and haemophagocytosis index of Entamoeba histolytica. Indian J Med Res 1982;76:545 51.
36. Niggli F, Halle F, Seger RA. Immunologic complications of visceral leishmaniasis. Monatsschrift Kinderheilkunde 1991; 139:772-4.
37. Ramanathan M, Karim N. Haemophagocytosis in typhoid fever. Med J Malaysia 1993;48:240 3.
38. Quiquandon I, Plantier I, Hatron PY, et al. Tuberculosis associated haemophagocytic syndrome: two cases with a favourable outcome. Nour Rev Fr Hamatol 1995;37:149 52.
39. Mandel H, Gozal D, Aizin A, et al. Haemophagocytosis in hereditary fructose intolerance: a diagnostic dilemma. J Inherit Metab Dis 1990;13:267 9.
40. Neve P, Decaux G. Still's disease in adults. Rev Med Brux 1991;12:399-401.
41. Gill DS, Spencer A, Cobcroft RG. High-dose gamma globulin therapy in the reactive haemophagocytic syndrome. Br J Haematol 1994;88:204 6.
42. Stark R, Manoharan A. Haemophagocytic syndrome complicating acute lymphoblastic leukaemia. Postgrad Med J 1989;65:249 52.
43. Wong KF, Chan JK, Ng CS, et al. Erythroleukaemia-associated haemophagocytic syndrome. Clin Lab Haematol 1991;13:383 6.
44. Prussia PR, Mansoor GA, Edwards C, et al. Haemophagocytic syndrome. W Indian Med J 1991;40:188-92.
45. Dich NH, Goodman ZD, Klein MA. Hepatic involvement in Hodgkin's disease: clues to histologic diagnosis. Cancer 1989;64:2121 6.
46. Hubscher SG, Lumley MA, Elias E. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma. Hepatology 1993;17:70 7.
47. Hsu SM, Xie SS, Hsu PL. et al. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease. Am J Pathol 1992;141:129 38.
48. Reinhold U, Abken H, Kukel S. Tumor infiltrating lymphocytes isolated from a Ki-1 positive large cell lymphoma of the skin. Phenotypic characterization and analysis of cytokine secretion. Cancer 1991;68:2155 60.
49. Woolf GM, Vierling JM. Disappearing intrahepatic bile ducts: the syndromes and their mechanisms. Semin Liver Dis 1993;13:261 75.
50. Perera DR, Greene ML, Fenster LF. Cholestasis associated with extrabiliary Hodgkin's disease. Gastroenterology 1974; 67:680 5.
51. Nakagawa K, Miller FN, Sims DE, et al. Mechanisms of interleukin-2-induced hepatic toxicity. Cancer Res 1996;56: 507 10.
52. Fang JW, Lau JY, Wu PC, et al. Fulminant hepatic failure in non metastatic renal cell carcinoma. Dig Dis Sci 1992;37: 474 7.
53. Kerbel RS, Waghorne C, Korczac B, et al. Clonal dominance of primary tumours by metastatic cells: genetic analysis and biological implications. Cancer Surv 1988;7: 597 629.
54. McMillan TJ, Hart IR. Can cancer chemotherapy enhance the malignant behaviour of tumours? Cancer and Metastasis Reviews 1987;6:505 20.